METROPOLIS HEALTHCARE
|
|
| BOM : 542650 NSE : METROPOLIS | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
May 24,2024 |
|
Price(EOD): ₹ 1,969.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 10,082.30 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| METROPOLIS HEALTHCARE | 7.1% | 7% | 56.7% |
| APOLLO HOSPITALS ENTERPRISE | -0.4% | -5.2% | 29.3% |
| MAX HEALTHCARE INSTITUTE | -6.6% | -2.9% | 45% |
| GLOBAL HEALTH | -15.8% | -17.9% | 108.4% |
| FORTIS HEALTHCARE | 2.1% | 2.5% | 64.4% |
| NARAYANA HRUDAYALAYA | -3.1% | -0.9% | 51% |
| ASTER DM HEALTHCARE | 5.2% | -4.6% | 40.9% |
| DR LAL PATHLABS | 3.6% | 12.7% | 27.7% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -3.7% | -7.3% | 17.5% |
FUNDAMENTAL ANALYSIS OF METROPOLIS HEALTHCARE
[ Q(TTM): Mar2024, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF METROPOLIS HEALTHCARE
[As on : May 24,2024
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
78.53
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 128.46 Cr
[Latest Qtr - Mar2024 - Consolidated Results ] 9.2
P/B Calculated based on Book Value of Rs 1,096.16 Cr
[Latest Year - Mar2024 - Consolidated Results ] 8.35
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,207.71 Cr
[Latest Qtr - Mar2024 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
20% 12% 3% |
SHARE PRICE MOMENTUM OF METROPOLIS HEALTHCARE
METROPOLIS HEALTHCARE vs SENSEX
DEBT OF METROPOLIS HEALTHCARE
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2023 2022 2021 Avg_3yrs |
0.09 0.31 0 0.13 |
0.08 0.3 0 0.13 |
|
[Last Annual Data : Mar2023]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF METROPOLIS HEALTHCARE
| Pledged Promoter Shares |
1.18 % | |
|---|---|---|
| As on : Dec2023 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF METROPOLIS HEALTHCARE
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
13.7% 23.33% 37.11% 33.85% |
17.15% 13.79% 20.59% 9.07% |
| QtrlyTrend |
8 | |
| Latest Qtr: Mar2024 | ||
| Quarterly Result Analysis → | ||
METROPOLIS HEALTHCARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE 500 | 2% | 4.1% | 38.5% |
| S&P BSE ALLCAP | 1.9% | 3.9% | 40.2% |
| S&P BSE 400 MIDSMALLCAP | 1.2% | 5.5% | 59.5% |
| S&P BSE MIDSMALLCAP | 1.2% | 5.1% | 63.7% |
| S&P BSE SMALL CAP | 0.9% | 3.2% | 61.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 | 2% | 4% | 39.4% |
| NIFTY500 MULTICAP 50:25:25 | 1.6% | 4% | 47.1% |
| NIFTY MID SMALL400 | 1.2% | 4.8% | 61.6% |
| NIFTY SMALLCAP250 | 0.5% | 2.5% | 64% |
| NIFTY HEALTHCARE | 0.2% | 3.5% | 53.4% |
You may also like the below Video Courses
FAQ about METROPOLIS HEALTHCARE
Is METROPOLIS HEALTHCARE good for long term investment?
As on May 24,2024, the Fundamentals of METROPOLIS HEALTHCARE look Strong and hence it may be good for long term investment! See Financial Performance of METROPOLIS HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is METROPOLIS HEALTHCARE UnderValued or OverValued?
As on May 24,2024, METROPOLIS HEALTHCARE is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of METROPOLIS HEALTHCARE ?
As on May 24,2024, the Intrinsic Value of METROPOLIS HEALTHCARE is Rs. 1,755.70 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,643.70
Fair Value [Median EV / Sales Model] : Rs. 1,755.70
Fair Value [Median Price / Sales Model] : Rs. 1,914.73
Estimated Median Fair Value of METROPOLIS HEALTHCARE : Rs. 1,755.70
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
